|
|
New Products
|
|
|
|
|
Effective and more convenient than injectable treatments
|
|
|
|
|
|
|
|
|
|
|
|
An option for achieving transfusion independence in the absence of a compatible donor
|
|
|
|
|
|
|
|
|
|
|
|
A backup option in cases of carbapenem resistance
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reviews
|
|
|
|
|
Non-pharmacological measures first, then paracetamol or ibuprofen
|
|
|
|
|
|
|
|
|
|
Survival extended with osimertinib as first-line therapy
|
|
|
|
|
|
|
|
|
|
|
|